Skip to Content
Merck

Biotransformation of flurbiprofen by Cunninghamella species.

Applied and environmental microbiology (2010-07-27)
Jessica Amadio, Katherine Gordon, Cormac D Murphy
ABSTRACT

The biotransformation of the fluorinated anti-inflammatory drug flurbiprofen was investigated in Cunninghamella spp. Mono- and dihydroxylated metabolites were detected using gas chromatography-mass spectrometry and fluorine-19 nuclear magnetic resonance spectroscopy, and the major metabolite 4'-hydroxyflurbiprofen was isolated by preparative high-pressure liquid chromatography (HPLC). Cunninghamella elegans DSM 1908 and C. blakesleeana DSM 1906 also produced a phase II (conjugated) metabolite, which was identified as the sulfated drug via deconjugation experiments.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Flurbiprofen, cyclooxygenase inhibitor